Diabetic ketoacidosis inducing myocardial infarction secondary to treatment with dapagliflozin: a case report.
Clin Case Rep
; 5(6): 809-811, 2017 06.
Article
en En
| MEDLINE
| ID: mdl-28588816
ABSTRACT
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are able to provoke diabetic ketoacidosis (DKA) with absence or low levels of ketone bodies in urine and slightly elevated blood glucose levels, which could delay the diagnosis; however, the presence of high urine output, due to the excretion of glucose, can help to identify the true cause.
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Clin Case Rep
Año:
2017
Tipo del documento:
Article